Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9622316 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686462 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686890 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686433 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686608 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686845 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686556 | 1.00 | TSHR (0.50) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL838158 | 0.97 | TSHR (0.44) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL1686782 | 0.87 | TSHR (0.40) | TSHRTHRBLMNAALDH1A1HSD17B10 | |
| SCHEMBL4530355 | 0.84 | DNM1 (0.43) | TSHRTHRBLMNAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932330-B2 | Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-26 | — | — | US | disclosed |
| US-7592402-B2 | Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-09-22 | — | — | US | disclosed |
| US-20080319148-A1 | Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-12-25 | — | — | US | disclosed |
| US-7115539-B2 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20050245701-A1 | Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-11-03 | — | — | US | disclosed |
| US-20040209762-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209762-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | AP1M1, PYM1, SEM1 | TSHR 4012/4885THRB 4350/4885LMNA 1707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.